{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:42:40Z","timestamp":1761129760599,"version":"3.37.3"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Key Clinical Specialty of Shanghai","award":["No.shslczdzk06504"],"award-info":[{"award-number":["No.shslczdzk06504"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00228-020-02962-5","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T09:34:30Z","timestamp":1597138470000},"page":"13-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials"],"prefix":"10.1007","volume":"77","author":[{"given":"Can","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoye","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangzhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-1546","authenticated-orcid":false,"given":"Qianzhou","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"issue":"3","key":"2962_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269\u2013271. https:\/\/doi.org\/10.1038\/s41422-020-0282-0","journal-title":"Cell Res"},{"key":"2962_CR2","unstructured":"General Office of the Health Commission (2020) Covid-19 prevention and control plan (6th edn). http:\/\/www.nhc.gov.cn\/jkj\/s3577\/202003\/4856d5b0458141fa9f376853224d41d7\/files\/4132bf035bc242478a6eaf157eb0d979.pdf. Accessed 19 Mar 2020"},{"key":"2962_CR3","unstructured":"General Office of the Health Commission (2020) Covid-19 prevention and control plan (trial 7th edn). 2020. http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202003\/46c9294a7dfe4cef80dc7f5912eb1989\/files\/ce3e6945832a438eaae415350a8ce964.pdf. Accessed 19 Mar 2020"},{"issue":"1","key":"2962_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/0378-6323.38401","volume":"74","author":"A Pareek","year":"2008","unstructured":"Pareek A, Khopkar U, Sacchidanand S, Chandurkar N, Naik GS (2008) Comparative study of efficacy and safety of hydroxychloroquine and chloroquine in polymorphic light eruption: a randomized, double-blind, multicentric study. Indian J Dermatol Venereol Leprol 74(1):18\u201322. https:\/\/doi.org\/10.4103\/0378-6323.38401","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"2962_CR5","first-page":"692","volume":"12","author":"DS Finbloom","year":"1985","unstructured":"Finbloom DS, Silver K, Newsome DA, Gunkel R (1985) Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol 12(4):692\u2013694","journal-title":"J Rheumatol"},{"issue":"3","key":"2962_CR6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3899\/jrheum.161063","volume":"44","author":"A Srinivasa","year":"2017","unstructured":"Srinivasa A, Tosounidou S, Gordon C (2017) Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand-related issue? J Rheumatol 44(3):398. https:\/\/doi.org\/10.3899\/jrheum.161063","journal-title":"J Rheumatol"},{"issue":"6","key":"2962_CR7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/jac\/dkv018","volume":"70","author":"MA Al-Bari","year":"2015","unstructured":"Al-Bari MA (2015) Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother 70(6):1608\u20131621. https:\/\/doi.org\/10.1093\/jac\/dkv018","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2962_CR8","doi-asserted-by":"publisher","first-page":"S440","DOI":"10.1007\/11606.1525-1497","volume":"34","author":"A Ghincea","year":"2019","unstructured":"Ghincea A, Allsop J, Groves DW, Rizeq M, Revelo MP, Raghavan S (2019) A failing heart: a new diagnosis of heart failure due to hydroxychloroquine-induced cardiomyopathy. J Gen Intern Med 34(2):S440. https:\/\/doi.org\/10.1007\/11606.1525-1497","journal-title":"J Gen Intern Med"},{"issue":"4","key":"2962_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jim-2019-001036.46","volume":"67","author":"B Abbi","year":"2019","unstructured":"Abbi B, Patel SN, Blanco I, Kumthekar A, Schwartz D (2019) A growing concern: cardiomyopathy with long term hydroxychloroquine use. J Investig Med 67(4):807. https:\/\/doi.org\/10.1136\/jim-2019-001036.46","journal-title":"J Investig Med"},{"issue":"3","key":"2962_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ehf2.12276","volume":"5","author":"H Yogasundaram","year":"2018","unstructured":"Yogasundaram H, Hung W, Paterson ID, Sergi C, Oudit GY (2018) Chloroquine-induced cardiomyopathy: a reversible cause of heart failure. ESC heart failure 5(3):372\u2013375. https:\/\/doi.org\/10.1002\/ehf2.12276","journal-title":"ESC heart failure"},{"issue":"1109","key":"2962_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/postgradmedj-2017-135236","volume":"94","author":"MU Dogar","year":"2018","unstructured":"Dogar MU, Shah NN, Ishtiaq S, Shah PN, Shah P, Mathew S et al (2018) Hydroxychloroquine-induced restrictive cardiomyopathy: a case report. Postgrad Med J 94(1109):185\u2013186. https:\/\/doi.org\/10.1136\/postgradmedj-2017-135236","journal-title":"Postgrad Med J"},{"issue":"1\u20132","key":"2962_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000500406","volume":"104","author":"G Liccioli","year":"2019","unstructured":"Liccioli G, Marrani E, Giani T, Simonini G, Barni S, Mori F (2019) The first pediatric case of acute generalized Exanthematous Pustulosis caused by hydroxychloroquine. Pharmacology 104(1\u20132):57\u201359. https:\/\/doi.org\/10.1159\/000500406","journal-title":"Pharmacology"},{"issue":"3","key":"2962_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1590\/abd1806-4841.20175561","volume":"92","author":"H Duman","year":"2017","unstructured":"Duman H, Topal IO, Kocaturk E, Cure K, Mansuroglu I (2017) Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation. An Bras Dermatol 92(3):404\u2013406. https:\/\/doi.org\/10.1590\/abd1806-4841.20175561","journal-title":"An Bras Dermatol"},{"issue":"6","key":"2962_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.4103\/0253-7613.169589","volume":"47","author":"O Charfi","year":"2015","unstructured":"Charfi O, Kastalli S, Sahnoun R, Lakhoua G (2015) Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing. Indian journal of pharmacology 47(6):693\u2013694. https:\/\/doi.org\/10.4103\/0253-7613.169589","journal-title":"Indian journal of pharmacology"},{"key":"2962_CR15","doi-asserted-by":"publisher","unstructured":"Ivo R, Lopes CA, Reis R (2018) Woman in grey: hydroxychloroquine-induced hyperpigmentation. BMJ Case Rep 11(1):e227305. https:\/\/doi.org\/10.1136\/bcr-2018-227305","DOI":"10.1136\/bcr-2018-227305"},{"issue":"2","key":"2962_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/ddg.12232","volume":"12","author":"RS Kasper","year":"2014","unstructured":"Kasper RS, Flueckiger B, Gobbi S, Lautenschlager S, Borelli S (2014) Hydroxychloroquine-induced hyperpigmentation. JDDG 12(2):158\u2013161. https:\/\/doi.org\/10.1111\/ddg.12232","journal-title":"JDDG"},{"issue":"12","key":"2962_CR17","first-page":"19","volume":"19","author":"A Mir","year":"2013","unstructured":"Mir A, Boyd KP, Meehan SA, McLellan B (2013) Hydroxychloroquine-induced hyperpigmentation. Dermatol Online J 19(12):19","journal-title":"Dermatol Online J"},{"issue":"12","key":"2962_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10067-009-1262-4","volume":"28","author":"A Lateef","year":"2009","unstructured":"Lateef A, Tan KB, Lau TC (2009) Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine. Clin Rheumatol 28(12):1449\u20131452. https:\/\/doi.org\/10.1007\/s10067-009-1262-4","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2962_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1365-2230.2008.02704.x","volume":"33","author":"EL Callaly","year":"2008","unstructured":"Callaly EL, FitzGerald O, Rogers S (2008) Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis. Clin Exp Dermatol 33(5):572\u2013574. https:\/\/doi.org\/10.1111\/j.1365-2230.2008.02704.x","journal-title":"Clin Exp Dermatol"},{"key":"2962_CR20","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"2962_CR21","unstructured":"What is a Serious Adverse Event? 2016. https:\/\/www.fda.gov\/safety\/reporting-serious-problems-fda\/what-serious-adverse-event. Accessed 19 Mar 2020"},{"issue":"2","key":"2962_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20(2):109\u2013117. https:\/\/doi.org\/10.2165\/00002018-199920020-00002","journal-title":"Drug Saf"},{"key":"2962_CR23","doi-asserted-by":"crossref","unstructured":"Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors) (2019) Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"key":"2962_CR24","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed) 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ (Clinical research ed)"},{"key":"2962_CR25","unstructured":"The Cochrane Collaboration (2014) Review Manager (RevMan). [Computer Program]. Version 5.3. Copenhagen DTNCC"},{"key":"2962_CR26","unstructured":"Chen J, Liu DP, Liu L, Liu P et al (2020) A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). J Zhejiang Univ (Med Sci):1\u20138"},{"issue":"10","key":"2962_CR27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/art.1780381011","volume":"38","author":"WD Blackburn Jr","year":"1995","unstructured":"Blackburn WD Jr, Prupas HM, Silverfield JC, Poiley JE, Caldwell JR, Collins RL et al (1995) Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone. Arthritis Rheum 38(10):1447\u20131456. https:\/\/doi.org\/10.1002\/art.1780381011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2962_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.23822\/EurAnnACI.1764-1489.11","volume":"49","author":"T Boonpiyathad","year":"2017","unstructured":"Boonpiyathad T, Sangasapaviliya A (2017) Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study. Eur Ann Allergy Clin Immunol 49(5):220\u2013224. https:\/\/doi.org\/10.23822\/EurAnnACI.1764-1489.11","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"11","key":"2962_CR29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.7326\/0003-4819-119-11-199312010-00002","volume":"119","author":"P Clark","year":"1993","unstructured":"Clark P, Casas E, Tugwell P, Medina C, Gheno C, Tenorio G et al (1993) Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial. Ann Intern Med 119(11):1067\u20131071. https:\/\/doi.org\/10.7326\/0003-4819-119-11-199312010-00002","journal-title":"Ann Intern Med"},{"issue":"2","key":"2962_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0002-9343(99)80399-4","volume":"98","author":"JM Esdaile","year":"1995","unstructured":"Esdaile JM, Suissa S, Shiroky JB, Lamping D, Tsakonas E, Anderson D et al (1995) A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA study. Am J Med 98(2):156\u2013168. https:\/\/doi.org\/10.1016\/S0002-9343(99)80399-4","journal-title":"Am J Med"},{"issue":"3","key":"2962_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Pu\u00e9chal X, Le Guern V, Sibilia J, Goeb V et al (2014) Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial. Jama 312(3):249\u2013258. https:\/\/doi.org\/10.1001\/jama.2014.7682","journal-title":"Jama"},{"issue":"3","key":"2962_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/03009749309099254","volume":"22","author":"D Haar","year":"1993","unstructured":"Haar D, S\u00f8lvkjaer M, Unger B, Rasmussen KJ, Christensen L, Hansen TM (1993) A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis. Scand J Rheumatol 22(3):113\u2013118. https:\/\/doi.org\/10.3109\/03009749309099254","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"2962_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2106\/00004623-197658080-00008","volume":"58","author":"EH Hansen","year":"1976","unstructured":"Hansen EH, Jessing P, Lindewald H (1976) Hydroxychloroquine sulphate in prevention of deep venous thrombosis following fracture of the hip, pelvis, or thoracolumbar spine. J Bone Joint Surg Am 58(8):1089\u20131093. https:\/\/doi.org\/10.2106\/00004623-197658080-00008","journal-title":"J Bone Joint Surg Am"},{"key":"2962_CR34","doi-asserted-by":"publisher","unstructured":"Horne GA, Stobo J, Kelly C, Mukhopadhyay A, Latif AL, Dixon-Hughes J et al (2020) A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. Leukemia. https:\/\/doi.org\/10.1038\/s41375-019-0700-9","DOI":"10.1038\/s41375-019-0700-9"},{"issue":"3","key":"2962_CR35","first-page":"221","volume":"38","author":"M Jokar","year":"2013","unstructured":"Jokar M, Mirfeizi Z, Keyvanpajouh K (2013) The effect of hydroxychloroquine on symptoms of knee osteoarthritis: a double-blind randomized controlled clinical trial. Iran J Med Sci 38(3):221\u2013226","journal-title":"Iran J Med Sci"},{"issue":"7","key":"2962_CR36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaoncol.2019.0684","volume":"5","author":"TB Karasic","year":"2019","unstructured":"Karasic TB, O'Hara MH, Loaiza-Bonilla A, Reiss KA, Teitelbaum UR, Borazanci E et al (2019) Effect of gemcitabine and nab-paclitaxel with or without hydroxychloroquine on patients with advanced pancreatic cancer: a phase 2 randomized clinical trial. JAMA oncology 5(7):993\u2013998. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0684","journal-title":"JAMA oncology"},{"issue":"1","key":"2962_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00124743-199702000-00002","volume":"3","author":"A Kavanaugh","year":"1997","unstructured":"Kavanaugh A, Adams-Huet B, Jain R, Denke M, McFarlin J (1997) Hydroxychloroquine effects on lipoprotein profiles (the HELP trial): a double-blind, randomized, placebo-controlled, pilot study in patients with systemic lupus erythematosus. J Clin Rheumatol 3(1):3\u20138. https:\/\/doi.org\/10.1097\/00124743-199702000-00002","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"2962_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.7326\/M17-1430","volume":"168","author":"SR Kingsbury","year":"2018","unstructured":"Kingsbury SR, Tharmanathan P, Keding A, Ronaldson SJ, Grainger A, Wakefield RJ et al (2018) Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis a randomized trial. Ann Intern Med 168(6):385\u2013395. https:\/\/doi.org\/10.7326\/M17-1430","journal-title":"Ann Intern Med"},{"issue":"9","key":"2962_CR39","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/acr.23471","volume":"70","author":"W Lee","year":"2018","unstructured":"Lee W, Ruijgrok L, Boxma-de Klerk B, Kok MR, Kloppenburg M, Gerards A et al (2018) Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res 70(9):1320\u20131325. https:\/\/doi.org\/10.1002\/acr.23471","journal-title":"Arthritis Care Res"},{"issue":"1","key":"2962_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.ajkd.2019.01.026","volume":"74","author":"LJ Liu","year":"2019","unstructured":"Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN et al (2019) Effects of hydroxychloroquine on proteinuria in IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 74(1):15\u201322. https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.026","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2962_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ijantimicag.2017.08.009","volume":"51","author":"MM Majzoobi","year":"2018","unstructured":"Majzoobi MM, Hashemi SH, Mamani M, Keramat F, Poorolajal J, Ghasemi Basir HR (2018) Effect of hydroxychloroquine on treatment and recurrence of acute brucellosis: a single-blind, randomized clinical trial. Int J Antimicrob Agents 51(3):365\u2013369. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.009","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"2962_CR42","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1185\/03007995.2015.1087989","volume":"31","author":"A Pareek","year":"2015","unstructured":"Pareek A, Chandurkar N, Thulaseedharan NK, Legha R, Agarwal M, Mathur SL et al (2015) Efficacy and safety of fixed dose combination of atorvastatin and hydroxychloroquine: a randomized, double-blind comparison with atorvastatin alone among Indian patients with dyslipidemia. Curr Med Res Opin 31(11):2105\u20132117. https:\/\/doi.org\/10.1185\/03007995.2015.1087989","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"2962_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/jama.2012.6936","volume":"308","author":"NI Paton","year":"2012","unstructured":"Paton NI, Goodall RL, Dunn DT, Franzen S, Collaco-Moraes Y, Gazzard BG et al (2012) Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial. JAMA 308(4):353\u2013361. https:\/\/doi.org\/10.1001\/jama.2012.6936","journal-title":"JAMA"},{"issue":"2","key":"2962_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/rheumatology\/28.2.128","volume":"28","author":"DL Scott","year":"1989","unstructured":"Scott DL, Dawes PT, Tunn E, Fowler PD, Shadforth MF, Fisher J et al (1989) Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study. Br J Rheumatol 28(2):128\u2013133. https:\/\/doi.org\/10.1093\/rheumatology\/28.2.128","journal-title":"Br J Rheumatol"},{"issue":"4","key":"2962_CR45","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/0149-2918(95)80039-5","volume":"17","author":"K Sperber","year":"1995","unstructured":"Sperber K, Louie M, Kraus T, Proner J, Sapira E, Lin S et al (1995) Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther 17(4):622\u2013636. https:\/\/doi.org\/10.1016\/0149-2918(95)80039-5","journal-title":"Clin Ther"},{"issue":"4","key":"2962_CR46","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/art.40018","volume":"69","author":"N Yokogawa","year":"2017","unstructured":"Yokogawa N, Eto H, Tanikawa A, Ikeda T, Yamamoto K, Takahashi T et al (2017) Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: a multicenter, double-blind, randomized, parallel-group trial. Arthritis Rheumatol 69(4):791\u2013799. https:\/\/doi.org\/10.1002\/art.40018","journal-title":"Arthritis Rheumatol"},{"key":"2962_CR47","doi-asserted-by":"publisher","unstructured":"Zeh H, Bahary N, Boone BA, Singhi AD, Miller-Ocuin JL, Normolle DP et al (2020) A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine\/nab-paclitaxel in pancreatic Cancer patients. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-4042","DOI":"10.1158\/1078-0432.Ccr-19-4042"},{"issue":"3","key":"2962_CR48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/0961203317724219","volume":"27","author":"D Erkan","year":"2018","unstructured":"Erkan D, Unlu O, Sciascia S, Belmont HM, Branch DW, Cuadrado MJ et al (2018) Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease. Lupus 27(3):399\u2013406. https:\/\/doi.org\/10.1177\/0961203317724219","journal-title":"Lupus"},{"issue":"12","key":"2962_CR49","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/jmv.24575","volume":"88","author":"GK Helal","year":"2016","unstructured":"Helal GK, Gad MA, Abd-Ellah MF, Eid MS (2016) Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients. J Med Virol 88(12):2170\u20132178. https:\/\/doi.org\/10.1002\/jmv.24575","journal-title":"J Med Virol"},{"issue":"9","key":"2962_CR50","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1185\/030079907x219634","volume":"23","author":"SK Das","year":"2007","unstructured":"Das SK, Pareek A, Mathur DS, Wanchu A, Srivastava R, Agarwal GG et al (2007) Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience. Curr Med Res Opin 23(9):2227\u20132234. https:\/\/doi.org\/10.1185\/030079907x219634","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2962_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0168-8227(01)00325-4","volume":"55","author":"HC Gerstein","year":"2002","unstructured":"Gerstein HC, Thorpe KE, Wayne Taylor D, Brian Haynes R (2002) The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas-a randomized trial. Diabetes Res Clin Pract 55(3):209\u2013219. https:\/\/doi.org\/10.1016\/S0168-8227(01)00325-4","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"2962_CR52","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00004714-200210000-00011","volume":"22","author":"M Desta","year":"2002","unstructured":"Desta M, Tadesse A, Gebre N, Barci BM, Torrey EF, Knable MB (2002) Controlled trial of hydroxychloroquine in schizophrenia. J Clin Psychopharmacol 22(5):507\u2013510. https:\/\/doi.org\/10.1097\/00004714-200210000-00011","journal-title":"J Clin Psychopharmacol"},{"issue":"9280","key":"2962_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0140-6736(01)05623-9","volume":"358","author":"WA Van Gool","year":"2001","unstructured":"Van Gool WA, Weinstein HC, Scheltens PK, Walstra GJM (2001) Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet 358(9280):455\u2013460. https:\/\/doi.org\/10.1016\/S0140-6736(01)05623-9","journal-title":"Lancet"},{"issue":"12","key":"2962_CR54","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/rheumatology\/39.12.1374","volume":"39","author":"CHM Van Jaarsveld","year":"2000","unstructured":"Van Jaarsveld CHM, Jahangier ZN, Jacobs JWG, Blaauw AAM, Van Albada-Kuipers GA, Ter Borg EJ et al (2000) Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis. Rheumatology 39(12):1374\u20131382. https:\/\/doi.org\/10.1093\/rheumatology\/39.12.1374","journal-title":"Rheumatology"},{"issue":"2","key":"2962_CR55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/s0091-6749(98)70086-7","volume":"102","author":"BL Charous","year":"1998","unstructured":"Charous BL, Halpern EF, Steven GC (1998) Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma. J Allergy Clin Immunol 102(2):198\u2013203. https:\/\/doi.org\/10.1016\/s0091-6749(98)70086-7","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"2962_CR56","first-page":"1457","volume":"21","author":"HJ Williams","year":"1994","unstructured":"Williams HJ, Egger MJ, Singer JZ, Willkens RF, Kalunian KC, Clegg DO et al (1994) Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. J Rheumatol 21(8):1457\u20131462","journal-title":"J Rheumatol"},{"issue":"10","key":"2962_CR57","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/ard.52.10.711","volume":"52","author":"KL Faarvang","year":"1993","unstructured":"Faarvang KL, Egsmose C, Kryger P, P\u00f8denphant J, Ingeman-Nielsen M, Hansen TM (1993) Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial. Ann Rheum Dis 52(10):711\u2013715. https:\/\/doi.org\/10.1136\/ard.52.10.711","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2962_CR58","doi-asserted-by":"publisher","first-page":"678","DOI":"10.7326\/0003-4819-112-9-678","volume":"112","author":"A Quatraro","year":"1990","unstructured":"Quatraro A, Consoli G, Magno M, Caretta F, Nardozza A, Ceriello A et al (1990) Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? Ann Intern Med 112(9):678\u2013681. https:\/\/doi.org\/10.7326\/0003-4819-112-9-678","journal-title":"Ann Intern Med"},{"issue":"3","key":"2962_CR59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/art.1780270304","volume":"27","author":"TW Bunch","year":"1984","unstructured":"Bunch TW, O'Duffy JD, Tompkins RB, O'Fallon WM (1984) Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum 27(3):267\u2013276. https:\/\/doi.org\/10.1002\/art.1780270304","journal-title":"Arthritis Rheum"},{"key":"2962_CR60","doi-asserted-by":"publisher","unstructured":"Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D et al (2020) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. medRxiv:2020.03.22.20040758. https:\/\/doi.org\/10.1101\/2020.03.22.20040758","DOI":"10.1101\/2020.03.22.20040758"},{"key":"2962_CR61","doi-asserted-by":"publisher","first-page":"m1849","DOI":"10.1136\/bmj.m1849","volume":"369","author":"W Tang","year":"2020","unstructured":"Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W et al (2020) Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial. BMJ 369:m1849. https:\/\/doi.org\/10.1136\/bmj.m1849","journal-title":"BMJ"},{"issue":"4","key":"2962_CR62","doi-asserted-by":"publisher","first-page":"102491","DOI":"10.1016\/j.autrev.2020.102491","volume":"19","author":"E Kravvariti","year":"2020","unstructured":"Kravvariti E, Koutsogianni A, Samoli E, Sfikakis PP, Tektonidou MG (2020) The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: a pilot open label randomized prospective study. Autoimmun Rev 19(4):102491. https:\/\/doi.org\/10.1016\/j.autrev.2020.102491","journal-title":"Autoimmun Rev"},{"key":"2962_CR63","doi-asserted-by":"publisher","unstructured":"Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC et al (2020) A randomized trial of hydroxychloroquine as Postexposure prophylaxis for Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2016638","DOI":"10.1056\/NEJMoa2016638"},{"key":"2962_CR64","doi-asserted-by":"publisher","first-page":"iii246","DOI":"10.1093\/neuonc\/noy139","volume":"20","author":"L Brazil","year":"2018","unstructured":"Brazil L, Swampillai A, Mak K, Hackshaw A, Edwards D, Mesiri P et al (2018) Hydroxychloroquine and short course radiotherapy for elderly patients with glioma: a randomised study. Neuro-Oncology 20:iii246. https:\/\/doi.org\/10.1093\/neuonc\/noy139","journal-title":"Neuro-Oncology"},{"issue":"7","key":"2962_CR65","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3346\/jkms.2016.31.7.1127","volume":"31","author":"CH Yoon","year":"2016","unstructured":"Yoon CH, Lee HJ, Lee EY, Lee EB, Lee WW, Kim MK et al (2016) Effect of hydroxychloroquine treatment on dry eyes in subjects with primary Sj\u00f6gren's syndrome: a double-blind randomized control study. J Korean Med Sci 31(7):1127\u20131135. https:\/\/doi.org\/10.3346\/jkms.2016.31.7.1127","journal-title":"J Korean Med Sci"},{"issue":"13","key":"2962_CR66","first-page":"965","volume":"94","author":"J Meng","year":"2014","unstructured":"Meng J, Lu Y, Dong X, Liu H (2014) Long-term effects of hydroxychloroquine on metabolism of serum lipids and left ventricular structure and function in patients of systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi 94(13):965\u2013968","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2962_CR67","doi-asserted-by":"publisher","unstructured":"Abou-Raya S, Abou-Raya A, Khadrawe T (2014) Efficacy of hydroxychloroquine in the treatment of symptomatic knee osteoarthritis in older adults: a randomized placebo-controlled trial. Ann Rheum Dis 73. https:\/\/doi.org\/10.1136\/annrheumdis-2014-eular.2764","DOI":"10.1136\/annrheumdis-2014-eular.2764"},{"issue":"12","key":"2962_CR68","first-page":"1621","volume":"32","author":"F Chen","year":"2012","unstructured":"Chen F, Xue B, Wang H (2012) Analysis of the clinical efficacy of yiqi fumai injection combined hydroxychloroquine sulfate tablet for treating Sjogren's syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 32(12):1621\u20131623","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"10","key":"2962_CR69","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.bbmt.2007.06.012","volume":"13","author":"T Fong","year":"2007","unstructured":"Fong T, Trinkaus K, Adkins D, Vij R, Devine SM, Tomasson M et al (2007) A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 13(10):1201\u20131206. https:\/\/doi.org\/10.1016\/j.bbmt.2007.06.012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2962_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00296-003-0384-2","volume":"25","author":"P Sarzi-Puttini","year":"2005","unstructured":"Sarzi-Puttini P, D'Ingianna E, Fumagalli M, Scarpellini M, Fiorini T, Ch\u00e9ri\u00e9-Ligni\u00e8re EL et al (2005) An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis. Rheumatol Int 25(1):15\u201322. https:\/\/doi.org\/10.1007\/s00296-003-0384-2","journal-title":"Rheumatol Int"},{"issue":"4","key":"2962_CR71","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1444-0903.2004.00532.x","volume":"34","author":"GE Reeves","year":"2004","unstructured":"Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M (2004) Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 34(4):182\u2013186. https:\/\/doi.org\/10.1111\/j.1444-0903.2004.00532.x","journal-title":"Intern Med J"},{"issue":"6","key":"2962_CR72","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1191\/096120301678646137","volume":"10","author":"RA Levy","year":"2001","unstructured":"Levy RA, Vilela VS, Cataldo MJ, Ramos RC, Duarte JL, Tura BR et al (2001) Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10(6):401\u2013404. https:\/\/doi.org\/10.1191\/096120301678646137","journal-title":"Lupus"},{"issue":"5","key":"2962_CR73","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/ard.52.5.360","volume":"52","author":"AA Kruize","year":"1993","unstructured":"Kruize AA, Hen\u00e9 RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L et al (1993) Hydroxychloroquine treatment for primary Sj\u00f6gren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 52(5):360\u2013364. https:\/\/doi.org\/10.1136\/ard.52.5.360","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2962_CR74","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2133.1987.tb05852.x","volume":"116","author":"GM Murphy","year":"1987","unstructured":"Murphy GM, Hawk JL, Magnus IA (1987) Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol 116(3):379\u2013386. https:\/\/doi.org\/10.1111\/j.1365-2133.1987.tb05852.x","journal-title":"Br J Dermatol"},{"key":"2962_CR75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00003086-198103000-00003","volume":"155","author":"GA Snook","year":"1981","unstructured":"Snook GA, Chrisman OD, Wilson TC (1981) Thromboembolism after surgical treatment of hip fractures. Clin Orthop Relat Res 155:21\u201324","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"2962_CR76","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2106\/00004623-197759040-00013","volume":"59","author":"ED Cooke","year":"1977","unstructured":"Cooke ED, Dawson MH, Ibbotson RM, Bowcock SA, Ainsworth ME, Pilcher MF (1977) Failure of orally administered hydroxychloroquine sulphate to prevent venous thromboembolism following elective hip operations. J Bone Joint Surg Am 59(4):496\u2013500","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"2962_CR77","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2106\/00004623-197658070-00003","volume":"58","author":"OD Chrisman","year":"1976","unstructured":"Chrisman OD, Snook GA, Wilson TC, Short JY (1976) Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report. J Bone Joint Surg Am 58(7):918\u2013920","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"2962_CR78","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/nejm199101173240303","volume":"324","author":"Canadian Hydroxychloroquine Study Group","year":"1991","unstructured":"Canadian Hydroxychloroquine Study Group (1991) A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324(3):150\u2013154. https:\/\/doi.org\/10.1056\/nejm199101173240303","journal-title":"N Engl J Med"},{"issue":"4","key":"2962_CR79","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.1111\/ajd.12827","volume":"59","author":"T Kowalski","year":"2018","unstructured":"Kowalski T, Baker C, Mack HG (2018) Hydroxychloroquine retinal toxicity in two patients with dermatological conditions. Australas J Dermatol 59(4):e266\u2013e2e8. https:\/\/doi.org\/10.1111\/ajd.12827","journal-title":"Australas J Dermatol"},{"key":"2962_CR80","doi-asserted-by":"publisher","first-page":"ii61","DOI":"10.1093\/rheumatology\/kex062","volume":"56","author":"AB Allard","year":"2017","unstructured":"Allard AB, Bristow E, Coombes G, Hickey S, Johnson H, Mootoo R et al (2017) Hydroxychloroquine-induced retinal toxicity. Rheumatology 56:ii61\u2013iii2. https:\/\/doi.org\/10.1093\/rheumatology\/kex062","journal-title":"Rheumatology"},{"issue":"6","key":"2962_CR81","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jcjo.2015.08.003","volume":"50","author":"EV Navajas","year":"2015","unstructured":"Navajas EV, Krema H, Hammoudi DS, Lipton JH, Simpson ER, Boyd S et al (2015) Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease. Can J Ophthalmol 50(6):442\u2013450. https:\/\/doi.org\/10.1016\/j.jcjo.2015.08.003","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"2962_CR82","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archophthalmol.2010.321","volume":"129","author":"M Michaelides","year":"2011","unstructured":"Michaelides M, Stover NB, Francis PJ, Weleber RG (2011) Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol 129(1):30\u201339. https:\/\/doi.org\/10.1001\/archophthalmol.2010.321","journal-title":"Arch Ophthalmol"},{"issue":"9284","key":"2962_CR83","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/s0140-6736(01)06004-4","volume":"358","author":"G Klinger","year":"2001","unstructured":"Klinger G, Morad Y, Westall CA, Laskin C, Spitzer KA, Koren G et al (2001) Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 358(9284):813\u2013814. https:\/\/doi.org\/10.1016\/s0140-6736(01)06004-4","journal-title":"Lancet"},{"issue":"17","key":"2962_CR84","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm1304542","volume":"380","author":"C Proano","year":"2019","unstructured":"Proano C, Kimball GP (2019) Hydroxychloroquine retinal toxicity. N Engl J Med 380(17):e27. https:\/\/doi.org\/10.1056\/NEJMicm1304542","journal-title":"N Engl J Med"},{"issue":"12","key":"2962_CR85","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.4103\/ijo.IJO_899_18","volume":"66","author":"KD Piggott","year":"2018","unstructured":"Piggott KD, Apte R (2018) Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus. Indian J Ophthalmol 66(12):1861\u20131862. https:\/\/doi.org\/10.4103\/ijo.IJO_899_18","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"2962_CR86","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ophtha.2015.09.011","volume":"123","author":"VS Parikh","year":"2016","unstructured":"Parikh VS, Modi YS, Au A, Ehlers JP, Srivastava SK, Schachat AP et al (2016) Nonleaking cystoid macular edema as a presentation of hydroxychloroquine retinal toxicity. Ophthalmology 123(3):664\u2013666. https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.011","journal-title":"Ophthalmology"},{"issue":"12","key":"2962_CR87","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","volume":"14","author":"A Jorge","year":"2018","unstructured":"Jorge A, Ung C, Young LH, Melles RB, Choi HK (2018) Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Nat Rev Rheumatol 14(12):693\u2013703. https:\/\/doi.org\/10.1038\/s41584-018-0111-8","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"2962_CR88","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jaad.2019.04.068","volume":"81","author":"CD Gonzalez","year":"2019","unstructured":"Gonzalez CD, Hansen C, Clarke JT (2019) Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: a retrospective cohort study. J Am Acad Dermatol 81(3):859\u2013860. https:\/\/doi.org\/10.1016\/j.jaad.2019.04.068","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2962_CR89","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/1346-8138.14512","volume":"45","author":"C Kishi","year":"2018","unstructured":"Kishi C, Motegi SI, Yasuda M, Ishikawa O (2018) Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic\/cutaneous lupus erythematosus patients. J Dermatol 45(8):1020\u20131022. https:\/\/doi.org\/10.1111\/1346-8138.14512","journal-title":"J Dermatol"},{"issue":"7","key":"2962_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2014.04.003","volume":"143","author":"I Pastushenko","year":"2014","unstructured":"Pastushenko I, Gracia-Caza\u00f1a T, Morales-Moya AL, Grasa MP (2014) Acute cutaneous pustular eruption due to hydroxychloroquine. Medicina Clinica 143(7):e13. https:\/\/doi.org\/10.1016\/j.medcli.2014.04.003","journal-title":"Medicina Clinica"},{"key":"2962_CR91","first-page":"S278","volume":"28","author":"ME Wiles","year":"2013","unstructured":"Wiles ME, Klein R, Dressler DD, Rollin F (2013) Acute generalized exanthematous pustulosis in a lupus patient recently initiating hydroxychloroquine. J Gen Intern Med 28:S278","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2962_CR92","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.clinthera.2008.05.014","volume":"30","author":"A Paradisi","year":"2008","unstructured":"Paradisi A, Bugatti L, Sisto T, Filosa G, Amerio PL, Capizzi R (2008) Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature. Clin Ther 30(5):930\u2013940. https:\/\/doi.org\/10.1016\/j.clinthera.2008.05.014","journal-title":"Clin Ther"},{"issue":"3","key":"2962_CR93","first-page":"317","volume":"16","author":"A Martins","year":"2006","unstructured":"Martins A, Lopes LC, Paiva Lopes MJ, Rodrigues JC (2006) Acute generalized exanthematous pustulosis induced by hydroxychloroquine. Eur J Dermatol 16(3):317\u2013318","journal-title":"Eur J Dermatol"},{"key":"2962_CR94","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/jop.12796","volume":"48","author":"M Ladan","year":"2019","unstructured":"Ladan M, Shahid C (2019) A pigmented palate-hydroxychloroquine-related oral hyperpigmentation. J Oral Pathol Med 48:50. https:\/\/doi.org\/10.1111\/jop.12796","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"2962_CR95","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.reuma.2012.12.004","volume":"9","author":"WA Sifuentes Giraldo","year":"2013","unstructured":"Sifuentes Giraldo WA, Grandal Platero M, de la Puente Bujidos C, G\u00e1mir G\u00e1mir ML (2013) Generalized skin hyperpigmentation and longitudinal melanonychia secondary to treatment with hydroxychloroquine in systemic lupus erythematosus. Reumatologia Clinica 9(6):381\u2013382. https:\/\/doi.org\/10.1016\/j.reuma.2012.12.004","journal-title":"Reumatologia Clinica"},{"issue":"12","key":"2962_CR96","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1610-0387.2012.08055.x","volume":"10","author":"A Kalampalikis","year":"2012","unstructured":"Kalampalikis A, Goetze S, Elsner P (2012) Isolated hyperpigmentation of the oral mucosa due to hydroxychloroquine. J Dtsch Dermatol Ges 10(12):921\u2013922. https:\/\/doi.org\/10.1111\/j.1610-0387.2012.08055.x","journal-title":"J Dtsch Dermatol Ges"},{"issue":"12","key":"2962_CR97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D32T07Q0NW","volume":"15","author":"LK Morrison","year":"2009","unstructured":"Morrison LK, Nordlund JJ, Heffernan MP (2009) Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuation. Dermatol Online J. 15(12):15","journal-title":"Dermatol Online J"},{"issue":"6","key":"2962_CR98","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2710.2008.00955.x","volume":"33","author":"MA Melikoglu","year":"2008","unstructured":"Melikoglu MA, Melikoglu M, Gurbuz U, Budak BS, Kacar C (2008) Hydroxychloroquine-induced hyperpigmentation: a case report. J Clin Pharm Ther 33(6):699\u2013701. https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00955.x","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"2962_CR99","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1177\/0961203317700486","volume":"26","author":"E Bahloul","year":"2017","unstructured":"Bahloul E, Jallouli M, Garbaa S, Marzouk S, Masmoudi A, Turki H et al (2017) Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases. Lupus. 26(12):1304\u20131308. https:\/\/doi.org\/10.1177\/0961203317700486","journal-title":"Lupus."},{"issue":"8","key":"2962_CR100","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamadermatol.2013.709","volume":"149","author":"M Jallouli","year":"2013","unstructured":"Jallouli M, Frances C, Piette JC, DLT H, Moguelet P, Factor C et al (2013) Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study. JAMA Dermatol 149(8):935\u2013940. https:\/\/doi.org\/10.1001\/jamadermatol.2013.709","journal-title":"JAMA Dermatol"},{"issue":"4","key":"2962_CR101","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/rheumatology\/41.4.473","volume":"41","author":"MJ Leckie","year":"2002","unstructured":"Leckie MJ, Rees RG (2002) Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis. Rheumatology 41(4):473\u2013474. https:\/\/doi.org\/10.1093\/rheumatology\/41.4.473","journal-title":"Rheumatology"},{"key":"2962_CR102","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/imj.18_13578","volume":"47","author":"L Jindal","year":"2017","unstructured":"Jindal L, Welgemoed S, Smith R, Dunn S, Subiramanian S, Gowdie P et al (2017) A rare case of chronic non granulomatous supraglottitis and toxic epidermal necrolysis (ten) secondary to its treatment in a teenage girl. Intern Med J 47:10. https:\/\/doi.org\/10.1111\/imj.18_13578","journal-title":"Intern Med J"},{"key":"2962_CR103","doi-asserted-by":"crossref","unstructured":"Cameron MC, Word AP, Dominguez A (2014) Hydroxychloroquine-induced fatal toxic epidermal necrolysis complicated by angioinvasive rhizopus. Dermatology Online J 20(11)","DOI":"10.5070\/D32011024620"},{"issue":"5","key":"2962_CR104","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","volume":"157","author":"A Sidoroff","year":"2007","unstructured":"Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L et al (2007) Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol 157(5):989\u2013996. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08156.x","journal-title":"Br J Dermatol"},{"issue":"9 Supplement 1","key":"2962_CR105","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/S0735-1097(19)32754-8","volume":"73","author":"S Vinnakota","year":"2019","unstructured":"Vinnakota S, van Zyl M, Geske J (2019) Hydroxychloroquine cardiomyopathy in a patient with gene positive hypertrophic cardiomyopathy. J Am Coll Cardiol 73(9 Supplement 1):2148. https:\/\/doi.org\/10.1016\/S0735-1097(19)32754-8","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2962_CR106","doi-asserted-by":"publisher","first-page":"S551","DOI":"10.1007\/11606.1525-1497","volume":"34","author":"M Grzeskowiak","year":"2019","unstructured":"Grzeskowiak M, Pu D (2019) Hydroxychloroquine toxicity leading to cardiac arrest in a 23-year-old. J Gen Intern Med 34(2):S551\u2013S5S2. https:\/\/doi.org\/10.1007\/11606.1525-1497","journal-title":"J Gen Intern Med"},{"key":"2962_CR107","doi-asserted-by":"publisher","unstructured":"Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M (2018) Hydroxychloroquine-mediated cardiotoxicity with a false-positive (99m)technetium-labeled pyrophosphate scan for transthyretin-related cardiac amyloidosis. Circ Cardiovasc Imaging 11(1):e007059. https:\/\/doi.org\/10.1161\/circimaging.117.007059","DOI":"10.1161\/circimaging.117.007059"},{"issue":"11","key":"2962_CR108","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1016\/S0735-1097(17)35765-0","volume":"69","author":"S Shaikh","year":"2017","unstructured":"Shaikh S, Grewal V, Turk A, Montfort JH, Slawsky M, Catanzaro JC (2017) A rare cause of myocardial injury in a patient with systemic lupus erythematosus: hydroxychloroquine induced cardiomyopathy. J Am Coll Cardiol 69(11):2376. https:\/\/doi.org\/10.1016\/S0735-1097(17)35765-0","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2962_CR109","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/0897190016655726","volume":"30","author":"LA Sabato","year":"2017","unstructured":"Sabato LA, Mendes LA, Cox ZL (2017) Restrictive cardiomyopathy associated with long-term use of hydroxychloroquine for systemic lupus erythematosus. J Pharm Pract 30(5):571\u2013575. https:\/\/doi.org\/10.1177\/0897190016655726","journal-title":"J Pharm Pract"},{"key":"2962_CR110","doi-asserted-by":"publisher","first-page":"i56","DOI":"10.1093\/rheumatology\/kev088.020","volume":"54","author":"M Shaikh","year":"2015","unstructured":"Shaikh M, Chitale A, Stratton R (2015) Hydroxychloroquine induced cardiotoxicity: a rare complication of a common drug. Rheumatology 54:i56\u2013ii7. https:\/\/doi.org\/10.1093\/rheumatology\/kev088.020","journal-title":"Rheumatology"},{"issue":"12","key":"2962_CR111","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.cjca.2014.08.016","volume":"30","author":"H Yogasundaram","year":"2014","unstructured":"Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J et al (2014) Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol 30(12):1706\u20131715. https:\/\/doi.org\/10.1016\/j.cjca.2014.08.016","journal-title":"Can J Cardiol"},{"issue":"3","key":"2962_CR112","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000343142","volume":"123","author":"SM Bae","year":"2012","unstructured":"Bae SM, Jung HO, Ihm SM, Kim JJ, Chin JY, Kim TS et al (2012) Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication. Cardiology 123(3):197\u2013200. https:\/\/doi.org\/10.1159\/000343142","journal-title":"Cardiology"},{"key":"2962_CR113","doi-asserted-by":"publisher","unstructured":"Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC (2020) QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review. Heart Rhythm. https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.008","DOI":"10.1016\/j.hrthm.2020.05.008"},{"issue":"10","key":"2962_CR114","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","volume":"41","author":"C Chatre","year":"2018","unstructured":"Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers YM (2018) Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature. Drug Saf 41(10):919\u2013931. https:\/\/doi.org\/10.1007\/s40264-018-0689-4","journal-title":"Drug Saf"},{"key":"2962_CR115","doi-asserted-by":"publisher","unstructured":"Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J et al (2020) Association of Treatment with Hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.8630","DOI":"10.1001\/jama.2020.8630"},{"issue":"11","key":"2962_CR116","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1136\/annrheumdis-2012-202322","volume":"72","author":"N Costedoat-Chalumeau","year":"2013","unstructured":"Costedoat-Chalumeau N, Galicier L, Auma\u00eetre O, Franc\u00e8s C, Le Guern V, Liot\u00e9 F et al (2013) Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS study). Ann Rheum Dis 72(11):1786\u20131792. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202322","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2962_CR117","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/1529-0131(199902)42:2<357::Aid-anr19>3.0.Co;2-j","volume":"42","author":"DE Furst","year":"1999","unstructured":"Furst DE, Lindsley H, Baethge B, Botstein GR, Caldwell J, Dietz F et al (1999) Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Arthritis Rheum 42(2):357\u2013365. https:\/\/doi.org\/10.1002\/1529-0131(199902)42:2<357::Aid-anr19>3.0.Co;2-j","journal-title":"Arthritis Rheum"},{"issue":"9453","key":"2962_CR118","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/s0140-6736(04)17670-8","volume":"365","author":"PM Rothwell","year":"2005","unstructured":"Rothwell PM (2005) External validity of randomised controlled trials: \"to whom do the results of this trial apply?\". Lancet 365(9453):82\u201393. https:\/\/doi.org\/10.1016\/s0140-6736(04)17670-8","journal-title":"Lancet"},{"issue":"17","key":"2962_CR119","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJMp038145","volume":"349","author":"WA Ray","year":"2003","unstructured":"Ray WA (2003) Population-based studies of adverse drug effects. N Engl J Med 349(17):1592\u20131594. https:\/\/doi.org\/10.1056\/NEJMp038145","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02962-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-02962-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02962-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T14:02:42Z","timestamp":1667743362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-02962-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2962"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-02962-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}